Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MMSI Stock Forecast 2026-2027
$69.95
Current Price
$4.16B
Market Cap
Buy 9
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to MMSI Price Targets
+74.4%
To High Target of $122.00
+44.4%
To Median Target of $101.00
+11.5%
To Low Target of $78.00
MMSI Price Momentum
-3.7%
1 Week Change
-14.3%
1 Month Change
-29.3%
1 Year Change
-20.6%
Year-to-Date Change
-34.8%
From 52W High of $107.27
+3.8%
From 52W Low of $67.42
📊 TOP ANALYST CALLS
Did MMSI Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Merit Medical is one of their latest high-conviction picks.
Latest MMSI Stock Price Targets & Analyst Predictions
Based on our analysis of 17 Wall Street analysts, MMSI has a bullish consensus with a median price target of $101.00 (ranging from $78.00 to $122.00). The overall analyst rating is Strong Buy (8.4/10). Currently trading at $69.95, the median forecast implies a 44.4% upside. This outlook is supported by 9 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Mike Matson at Needham, projecting a 74.4% upside. Conversely, the most conservative target is provided by Larry Biegelsen at Wells Fargo, suggesting a 11.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MMSI Analyst Ratings
9
Buy
2
Hold
0
Sell
MMSI Price Target Range
Low
$78.00
Average
$101.00
High
$122.00
Current: $69.95
Latest MMSI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MMSI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 26, 2026 | Wells Fargo | Larry Biegelsen | Equal-Weight | Downgrade | $78.00 |
| Feb 25, 2026 | Needham | Mike Matson | Buy | Maintains | $101.00 |
| Feb 25, 2026 | Barrington Research | Michael Petusky | Outperform | Maintains | $109.00 |
| Feb 18, 2026 | Piper Sandler | Jason Bednar | Overweight | Maintains | $106.00 |
| Feb 6, 2026 | BTIG | Sam Eiber | Buy | Initiates | $107.00 |
| Jan 9, 2026 | Needham | Mike Matson | Buy | Reiterates | $108.00 |
| Dec 17, 2025 | Canaccord Genuity | Jon Young | Buy | Maintains | $99.00 |
| Nov 14, 2025 | Canaccord Genuity | Jon Young | Buy | Maintains | $93.00 |
| Nov 14, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $95.00 |
| Nov 14, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $106.00 |
| Oct 31, 2025 | Piper Sandler | Jason Bednar | Overweight | Reiterates | $109.00 |
| Oct 31, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $106.00 |
| Oct 31, 2025 | Needham | Mike Matson | Buy | Reiterates | $108.00 |
| Oct 16, 2025 | Canaccord Genuity | Jon Young | Buy | Maintains | $104.00 |
| Oct 7, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $103.00 |
| Sep 23, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $103.00 |
| Jul 31, 2025 | Raymond James | Jayson Bedford | Outperform | Maintains | $102.00 |
| Jul 31, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $103.00 |
| Jul 31, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $100.00 |
| Jul 31, 2025 | Piper Sandler | Jason Bednar | Overweight | Maintains | $105.00 |
Merit Medical Systems, Inc. (MMSI) Competitors
The following stocks are similar to Merit Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
MMSI
Merit Medical
mkt cap
4.16B
Merit Medical Systems, Inc. (MMSI) Financial Data
Merit Medical Systems, Inc. has a market capitalization of $4.16B with a P/E ratio of 32.8x. The company generates $1.52B in trailing twelve-month revenue with a 8.5% profit margin.
Revenue growth is +10.9% quarter-over-quarter, while maintaining an operating margin of +15.8% and return on equity of +8.7%.
Valuation Metrics
Market Cap
$4.16B
Enterprise Value
$4.53B
P/E Ratio
32.8x
PEG Ratio
1.0x
Price/Sales
2.7x
Growth & Margins
Revenue Growth (YoY)
+10.9%
Gross Margin
+49.6%
Operating Margin
+15.8%
Net Margin
+8.5%
EPS Growth
+36.0%
Financial Health
Cash/Price Ratio
+10.7%
Current Ratio
4.3x
Debt/Equity
51.9x
ROE
+8.7%
ROA
+4.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Merit Medical Systems, Inc. (MMSI) Business Model
About Merit Medical Systems, Inc.
What They Do
Develops medical devices for diagnostic procedures.
Business Model
Merit Medical Systems manufactures and sells a wide range of medical devices used in various healthcare sectors such as cardiology, radiology, and oncology. The company generates revenue primarily through the sale of its products, which include catheters and procedural kits, to hospitals and healthcare providers globally.
Additional Information
Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical has built a strong global presence by distributing its products across multiple continents. The company focuses on innovation and high-quality standards to meet the evolving needs of the healthcare industry, ultimately enhancing patient care and healthcare service efficiency.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
7,400
CEO
Ms. Martha Goldberg Aronson
Country
United States
IPO Year
1992
Website
www.merit.comMerit Medical Systems, Inc. (MMSI) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
MMSI rides strong cardiovascular demand and fast-growing therapeutic devices, but tariffs, OEM weakness and China macro pressures cloud the outlook.
Mar 12, 2026
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
MMSI benefits from high cardiovascular demand and growth in therapeutic devices, but faces challenges from tariffs, OEM weakness, and macroeconomic pressures in China.
Why It Matters
MMSI's growth in cardiovascular devices signals opportunity, but tariffs and economic challenges in China introduce risks that may impact future performance and investor sentiment.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Zacks Premium offers Style Scores to help investors identify strong stocks across value, growth, and momentum strategies.
Why It Matters
Zacks Style Scores enhance stock selection across investment strategies, potentially improving returns and reducing risk, making it a valuable tool for informed investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Merit Medical (MMSI) and Straumann Holding AG (SAUHY) are both in the Medical - Dental Supplies sector, prompting investors to evaluate which stock offers better value currently.
Why It Matters
The comparison between Merit Medical and Straumann Holding AG indicates potential value disparities, guiding investment decisions in the Medical-Dental Supplies sector.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores can help investors identify strong stocks that may outperform the market for their investment portfolios.
Why It Matters
The Zacks Style Scores can guide investors in selecting high-performing stocks, potentially leading to better returns and improved portfolio performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Merit Medical Systems, Inc. (MMSI) held its Q4 2025 earnings call, detailing its financial performance for the quarter. Further specifics on revenue and guidance were discussed.
Why It Matters
Merit Medical's Q4 2025 earnings call provides insights into financial performance, growth prospects, and strategic direction, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Merit Medical (MMSI) reported quarterly earnings of $1.04 per share, surpassing the Zacks Consensus Estimate of $0.96 and up from $0.93 per share year-over-year.
Why It Matters
Merit Medical's earnings beat expectations and show year-over-year growth, indicating strong financial performance and potential for continued investor confidence and stock appreciation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About MMSI Stock
What is Merit Medical Systems, Inc.'s (MMSI) stock forecast for 2026?
Based on our analysis of 17 Wall Street analysts, Merit Medical Systems, Inc. (MMSI) has a median price target of $101.00. The highest price target is $122.00 and the lowest is $78.00.
Is MMSI stock a good investment in 2026?
According to current analyst ratings, MMSI has 9 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $69.95. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MMSI stock?
Wall Street analysts predict MMSI stock could reach $101.00 in the next 12 months. This represents a 44.4% increase from the current price of $69.95. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Merit Medical Systems, Inc.'s business model?
Merit Medical Systems manufactures and sells a wide range of medical devices used in various healthcare sectors such as cardiology, radiology, and oncology. The company generates revenue primarily through the sale of its products, which include catheters and procedural kits, to hospitals and healthcare providers globally.
What is the highest forecasted price for MMSI Merit Medical Systems, Inc.?
The highest price target for MMSI is $122.00 from Mike Matson at Needham, which represents a 74.4% increase from the current price of $69.95.
What is the lowest forecasted price for MMSI Merit Medical Systems, Inc.?
The lowest price target for MMSI is $78.00 from Larry Biegelsen at Wells Fargo, which represents a 11.5% increase from the current price of $69.95.
What is the overall MMSI consensus from analysts for Merit Medical Systems, Inc.?
The overall analyst consensus for MMSI is bullish. Out of 17 Wall Street analysts, 9 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $101.00.
How accurate are MMSI stock price projections?
Stock price projections, including those for Merit Medical Systems, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: March 15, 2026 6:14 AM UTC